NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL side effect
What is NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL ?Drugs associated with NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL
ADRIAMYCIN AVELOX BETASERON BEVACIZUMAB CYCLOSPORINE ERGENYL FABRAZYME MODIODAL NATALIZUMAB REBIF TAMOXIFEN TEMOZOLOMIDE TYSABRI TYVERBNUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Tyverb Side Effects Report #5589734-3
Physician from GERMANY reported TYVERB problem on Jan 10, 2008. Female patient was treated with TYVERB. After drug was administered, patient experienced the following problems/side effects: nuclear magnetic resonance imaging brain abnormal, . TYVERB dosage: unknown. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Ergenyl Side Effects Report #5522967-0
ERGENYL CHRONO problem was reported by a Consumer or non-health professional from GERMANY on Nov 12, 2007. Male patient was diagnosed with epilepsy and was treated with ERGENYL CHRONO. After drug was administered, patient experienced the following problems/side effects: nuclear magnetic resonance imaging brain abnormal, . ERGENYL CHRONO dosage: unknown. During the same period patient was treated with KEPPRA, TRILEPTAL. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Tysabri Side Effects Report #5671026-5
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Mar 03, 2008. Female patient, 60 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: hypothalamo-pituitary disorder, nuclear magnetic resonance imaging brain abnormal, . TYSABRI dosage: unknown. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Tysabri Side Effects Report #5623792-2
TYSABRI problem was reported by a Health Professional from UNITED STATES on Jan 24, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: meningioma, nuclear magnetic resonance imaging brain abnormal, . TYSABRI dosage: 300 MG; QM; IV. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Cyclosporine Side Effects Report #5550530-4
Consumer or non-health professional from UNITED STATES reported CYCLOSPORINE problem on Nov 26, 2007. Female patient, 32 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: diplegia, nuclear magnetic resonance imaging brain abnormal, . CYCLOSPORINE dosage: unknown. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Temozolomide Side Effects Report #5526285-6
TEMOZOLOMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Female patient, weighting 136.7 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: hemiparesis, nuclear magnetic resonance imaging brain abnormal, partial seizures, . TEMOZOLOMIDE dosage: 6160 MG. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Tamoxifen Side Effects Report #5481503-8
Health Professional from UNITED STATES reported TAMOXIFEN CITRATE problem on Oct 01, 2007. Female patient, 60 years of age, was diagnosed with breast cancer stage ii and was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, nuclear magnetic resonance imaging brain abnormal, . TAMOXIFEN CITRATE dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, DOCETAXEL. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Natalizumab Side Effects Report #5453441-8
NATALIZUMAB problem was reported by a Physician from UNITED STATES on Sept 06, 2007. Male patient, 43 years of age, weighting 220.0 lb, was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: convulsion, nuclear magnetic resonance imaging brain abnormal, . NATALIZUMAB dosage: 300 MG; QM; ;IV. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Fabrazyme Side Effects Report #5467098-3
Consumer or non-health professional from NETHERLANDS reported FABRAZYME problem on Sept 06, 2007. Male patient, 51 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, nuclear magnetic resonance imaging brain abnormal, oesophagitis, polyneuropathy, . FABRAZYME dosage: 0.2 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Modiodal Side Effects Report #5473270-9
MODIODAL problem was reported by a Consumer or non-health professional from FRANCE on Sept 17, 2007. Female patient, 22 years of age, was diagnosed with hypersomnia and was treated with MODIODAL. After drug was administered, patient experienced the following problems/side effects: motor dysfunction, nuclear magnetic resonance imaging brain abnormal, . MODIODAL dosage: 100 MG QD ORAL. During the same period patient was treated with COMBINED ORAL CONTRACEPTIVE. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Natalizumab Side Effects Report #5410321-1
Physician from UNITED STATES reported NATALIZUMAB problem on July 27, 2007. Male patient, 43 years of age, weighting 220.0 lb, was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: convulsion, nuclear magnetic resonance imaging brain abnormal, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Cyclosporine Side Effects Report #5391156-5
CYCLOSPORINE problem was reported by a Health Professional from ITALY on July 11, 2007. Female patient, 32 years of age, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: diplegia, nuclear magnetic resonance imaging brain abnormal, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Cyclosporine Side Effects Report #5391156-5
Health Professional from ITALY reported CYCLOSPORINE problem on July 11, 2007. Female patient, 32 years of age, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: diplegia, nuclear magnetic resonance imaging brain abnormal, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Bevacizumab Side Effects Report #5593773-6
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Jan 08, 2008. Male patient, 44 years of age, weighting 172.2 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: brain oedema, confusional state, nuclear magnetic resonance imaging brain abnormal, somnolence, . BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with KEPPRA, TEMOZOLOMIDE, STEROIDS, PAXIL. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Avelox Side Effects Report #5604079-0
Health Professional from UNITED STATES reported AVELOX problem on Jan 23, 2008. Female patient, 54 years of age, weighting 110.0 lb, was diagnosed with pneumonia, prophylaxis and was treated with AVELOX. After drug was administered, patient experienced the following problems/side effects: nervous system disorder, nuclear magnetic resonance imaging brain abnormal, photosensitivity reaction, psittacosis, visual disturbance, . AVELOX dosage: unknown. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Rebif Side Effects Report #5535316-9
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2007. Female patient, 38 years of age, weighting 170.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: abasia, encephalitis, nuclear magnetic resonance imaging brain abnormal, visual disturbance, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Fabrazyme Side Effects Report #5483870-8
Physician from NETHERLANDS reported FABRAZYME problem on Sept 25, 2007. Male patient, 51 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, gait disturbance, nuclear magnetic resonance imaging brain abnormal, oesophagitis, polyneuropathy, sensorimotor disorder, treatment failure, walking aid user, . FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with METOPROLOL, MONOCEDOCARD, NEXIUM, LIPITOR, LYRICA, ASPIRIN AND DIPYRIDAMOLE. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Betaseron Side Effects Report #5495026-3
BETASERON problem was reported by a Pharmacist from CANADA on Oct 10, 2007. Female patient was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: convulsion, nuclear magnetic resonance imaging brain abnormal, rash macular, viral infection, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL : Adriamycin Side Effects Report #5467645-1
Health Professional from UNITED STATES reported ADRIAMYCIN problem on Sept 19, 2007. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with ADRIAMYCIN. After drug was administered, patient experienced the following problems/side effects: headache, hypertension, nuclear magnetic resonance imaging brain abnormal, vision blurred, . ADRIAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.